South Korea vs United States: Coverage of the human papillomavirus vaccine
South Korea
67
in 2025
United States
66
in 2025
South Korea rank
45th
United States rank
48th
Coverage of the human papillomavirus vaccine over time
- South Korea
- United States
How they compare
South Korea currently reports 67 against 66 in United States, a difference of 1.
The two have swapped places 5 times across 8 shared years of data; in 2018 it was United States ahead.
South Korea ranks 45th and United States ranks 48th of 85 countries.
Across the 2 decades both report, South Korea averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | South Korea | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5 | 58.5 | 3 | United States |
| 2020s | 69 | 66.33 | 2.67 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, South Korea or United States?
- South Korea, at 67 against 66 in United States as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between South Korea and United States?
- 1, with South Korea ahead.
- How many years of comparable data are there for South Korea and United States?
- 8 years are reported by both, from 2018 to 2025.
- How do South Korea and United States rank globally for coverage of the human papillomavirus vaccine?
- South Korea ranks 45th and United States ranks 48th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.